ISSCA’s On-site Training in Portugal
MIAMI, Florida, January 23, 2023 – The Global Stem Cells Group (GSCG) announces its long-awaited hands-on training this March 9th, 10th & 11th, 2023
The GSCG, through its International Society for Stem Cell Application (ISSCA) division, is holding a personalized, hands-on training course at Regenera clinic, located in Oeiras, Lisboa, Portugal. Industry-leading instructors across the regenerative medicine field will lead this onsite training course. We believe this course is a Total Solution for clinics as ISSCA teams will teach and train doctors and caregivers on the recent advances in regenerative medicine and cellular-based treatments.
Lisboa’s First On-site Training
Benito Novas, CEO of Global Stem Cells Group and Vice President of ISSCA, notes that “regenerative medicine is the future of health and beauty industries as more research is conducted and products developed for doctors to offer a superior service.”
Benito adds, “the training course will take a highly visual format with global experts interacting with trainees and live patients used to teach about different stem cell reintegration and procedural techniques with locally available tools and facilities.
The Lisboa training is the first in the country to bring clinics into the fold of regenerative medicine and stem cell treatments. Regenera clinic will be the first to be ISSCA certified and apply cellular therapies and regenerative medicine. Dr. Roni Lara Moya will be appointed Portugal Chapter director on 9th March.
The course design considers the needs of local trainees using a thorough scheduling process. Initial consultations between the trainees and ISSCA will inform equipment and kits availability, materials, underlying costs, and any other needs to be met during the main event.
What is the On-site Training About?
The following are some of the areas the onsite-training course will focus on:
1. Learning from Experts
A panel of stem cell therapy and regenerative medicine experts will lead the one-on-one training sessions. Cell therapy, skin regeneration techniques, bone marrow extraction, tissue engineering, and many more applications of advanced technologies to advance personalized health will be practically illustrated.
2. Trainees-Centered Treatment Protocols
The training course is personalized to every doctor and clinician’s specialization and the illness they are targeting. For example, stem cell treatment sessions will include various reintegration methods based on patients’ medical history and condition. The trainees will also have a first-hand view of how technology pushes the boundaries of regenerative medicine from research to the derivation of cell lines and, as we are all working to the possible future of genetic alteration.
Local nurses and medical assistants will also have a chance to be part of the process by going through a fully skilled procedural session that improves their assistance to the doctors.
3. International Certification
As an acclaimed stakeholder in regenerative medicine and stem cell treatment, ISSCA offers globally recognized certification to doctors and practitioners, highlighting their fascinating journey in this highly demanded field. According to the appointed chapter director of Portugal, Dr. Roni Lara Moya- “the upcoming onsite training is one of its kind ever conducted in the country. Dr. Moya asserts that “the collaboration between ISSCA and Regenerative Biomedicine Regenerative Clinic stems from a growing demand for new technologies and cutting-edge treatments that support patients’ positive health outcomes.”
4. Trends in Regenerative & Stem Cell Treatment
The training will cover stem cell and regenerative medicine’s practical, legal, technical, and ethical aspects. Laws, technological developments, and ethical concerns will be a critical part of the training course.
All are welcome to share the fantastic excitement of stem cell science and its promising future.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians who aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The mission of the International Stem Cell Certification Agency (ISSCA) is to establish itself as a global leader in regenerative medicine certification, education, research, and training.
ISSCA provides certification training in cities worldwide because it recognizes the importance of standards and certifications in regenerative medicine as a medical specialty. To help more people, both locally and globally, as the demand for more doctors interested in and comfortable with regenerative medicine surges. ISSCA’s mission is to advance quality and uniformity in regenerative medicine worldwide.
About Global Stem Cells Group:
The Global Stem Cell Group is a family of several companies focused on stem cell medicine and research. The company uses its network to bring leadership in regenerative medicine training, research, and patient applications.
GSCG’s mission is to allow physicians to present the benefits of stem cell medicine to patients worldwide. The company also partners with policymakers, educators, and regulators to promote regenerative medicine.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website www.stemcellsgroup.com or call +1 305 560 5331
Safe Harbor Statement: Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
- Published in News
ISSCA to Conduct Regenerative Medicine Conference in Cancún, México
Miami, FL, December 19, 2022 – The International Association for Stem Cell Application (ISSCA) has announced plans to host Applications of Stem Cell Therapies in Medicine and Aesthetic Surgery, a regenerative medicine conference, in Cancun, Mexico, April 22, 23, and 24, 2023.
Growing knowledge can turn the tide in the clinical and translational spectrum of stem-cell-based research and therapy, and several obstacles must be overcome. ISSCA’s International Conference, champions new ideas to propel the shift from traditional healthcare to regenerative medicine and therapies. The Conference will also emphasize the role of cutting technology and developments in all areas of stem cell research.
April 22nd & 23rd
The Cancun event will feature a panel of internationally renowned experts on stem cells and regenerative medicine, who will offer a two-day rigorous scientific discourse on critical topics in stem cell research and clinical applications. Topics of focus at the conference include: Tissue engineering and regenerative medicine; updates in Stem Cell research Clinical applications of regenerative medicine and cellular therapies; the latest methods of harvest and isolation, and Non-invasive surgical protocols; strategies for successful delivery of cell products; Ethical and regulatory issues in stem cell technology; and taking advantage of the latest technologies to improve marketing and networking.
April 24th
The third day of the conference (April 24th) will involve intensive hands-on training sessions with ISSCA-certified instructors on stem cell therapy’s aesthetic and clinical applications.
Participants will gain experience and access to different technologies, brands, and products for stem cell therapy.
The leading international conference offers an excellent opportunity for medical practitioners and stakeholders to network and learn from the best in the industry.
All practitioners and stakeholders in the medical sector are invited, including:
- Doctors Researchers & innovators,
- Decision-makers and funding agencies,
- Experts seeking collaborative work on stem cell technology,
- Professional bodies, and
- Marketing professionals.
To learn more about the ISSCA Cancun, Mexico conference and to make a reservation, visit the https://www.issca.us/issca-world-conferences/ website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians who aspire to treat diseases and lessen human suffering through advances in science, technology, and regenerative medicine.
ISSCA updates its members on advances in stem cell research, MSC, exosomes, and regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
The international community provides a platform for practitioners to interact with scientists and build medical networks necessary for marketing.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities worldwide. The goal is to encourage more physicians to practice regenerative medicine and make it available to patients nationally and internationally. Incorporated under the Republic of Korea as a non-profit company, the ISSCA is focused on fostering excellence and standards in regenerative medicine.
About Global Stem Cells Group
Global Stem Cells Group is the parent company of six companies that are dedicated to stem cell research, solutions, and technology training. The group was founded in 2012 and combines dedicated researchers, patient educators, and physician trainers with the shared goal of meeting the need for high-end stem cell solutions and treatments.
Given that the group has a singular focus in this field, it is uniquely positioned to become the global leader in cellular medicine. In addition, by bringing together leading professionals in cellular medicine, it can discover issues that the industry faces and focus its research and development in this area. This specialization has, undoubtedly, enabled it to come up with solutions that address some of the significant issues that most stakeholders are facing in the industry.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
- Published in News
Global Stem Cells Group announces the opening of a new Stem Cell Center in Bandung, Indonesia
Miami, FL, December 12, 2022 – Global Stem Cells Group (GSCG) is pleased to announce the opening of a new Stem Cell Center in Bandung, Indonesia in partnership with the Dr. Yanti Aesthetic Clinic. This joint venture will be the second in the country as they already have another facility in the stunning City of Surabaya.
The New Global Stem Cell Group Facility is Expected to Transform the Regenerative Medicine Field
The GSCG’s new center in Bandung aims to increase awareness about the benefits of regenerative medicine. Its launch strengthened the relationship between GSCG and the Dr. Yanti Aesthetic Clinic. This new facility is expected to transform regenerative medicine in the following ways:
- Offering accessible stem cell therapy to Indonesians;
- Promoting regenerative medicine technology; and
- Inspiring other doctors and industry experts to explore regenerative medicine.
Top Government Officials Attended the Launch of the Global Stem Cell Group Office in Bandung
The launch of the new Global Stem Cell Group facility in Bandung was a remarkable event in the medical field. The Minister of Tourism was among the top officials that witnessed the launch. Furthermore, the office of the Vice President sent several representatives.
What the President of Global Stem Cell Group Has to Say
Benito Novas, the president of the GSCG, was among the top industry specialists that graced the launch of the company’s second facility in Indonesia. According to him, GSCG wants to make regenerative medicine readily available for patients worldwide. Likewise, the company is encouraging more doctors to adopt stem cell therapy’s clinical and aesthetic applications in their work.
Benito Novas said: “We are dedicated to making it possible for both doctors and patients in all parts of the world to experience the benefits of regenerative medicines. The company is expanding and establishing itself as a market leader.”
The Director of the Dr. Yanti Aesthetic Clinic Appreciates GSCG
Dr. Yanti Kushmiran, director of the DR. Yanti Aesthetic Clinic, is once again honored to be part of this step into the future of regenerative medicine with its second Stem Cell Center in Indonesia together with the leading company Global Stem Cells Group.
Regarding this new clinic, Dr. Yanti says “We are honored to be part of GSCG, which has a more than 10-year track record in the market and a strong international reputation and to open a second cell therapy and regenerative medicine center facility under the Stem Cell Center brand. We will be able to provide more services to our patients as a result of this new partnership.”
Another GSCG Clinic is Opening in Indonesia by January 2023
The Global Stem Cell Group will continue increasing patients’ access to advanced regenerative medicine. As a result, the company plans to open another branch in Jakarta, the Capital of Indonesia. GSCG and its partners plan to launch this third facility in January 2023.
About Global Stem Cell Group
The Global Stem Cell Group is a family of several companies focused on stem cell medicine and research. The company uses its network to bring leadership in regenerative medicine training, research, and patient applications.
GSCG’s mission is to allow physicians to present the benefits of stem cell medicine to patients worldwide. The company also partners with policymakers, educators, and regulators to promote regenerative medicine.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website www.stemcellsgroup.com or call +1 305 560 5331
- Published in News
New advances in osteoarthritis therapy with stem cells
FRIDAY, 18 NOVEMBER 2022 / PUBLISHED IN BLOG
Osteoarthritis is a rheumatic pathology that damages the articular cartilage. By joining two bones through the joint capsule, the joints are able to move, providing us with functional autonomy. An inner fluid called synovial fluid is usually found within joints, which is produced by the synovial membrane. Articular cartilage covers the ends of the bones that form the joint. As a result of damage to this articular cartilage, pain, stiffness, and functional impairment occur. Osteoarthritis is the most common joint disorder, usually beginning between the ages of 40 and 50, affecting to some degree almost everyone over the age of 80. Typically, osteoarthritis affects the spine, shoulders, fingers, hips, knees, and toe joints.
Potential of Stem Cell Therapies
Stem cell therapies have the potential to treat a broad spectrum of diseases, including osteoarthritis, rhizarthrosis, diabetes, neurodegenerative diseases, spinal cord injuries, and heart disease. By utilizing stem cells, regenerative medicine is capable of repairing tissues in affected areas. The main difference between lipogem therapy and other treatments for osteoarthritis is that lipogem therapy regenerates cartilage, avoids surgery and its sequelae, and improves the quality of life for patients.
Advances in Sports Medicine and Traumatology
The potential for medical treatments with stem cells and their by-products is currently very high. In the field of sports medicine and traumatology, one of the most outstanding advances has been made for the first time in decades recently: Spanish scientists have achieved a degree of tendon regeneration in 100% of injured patients, resulting in a decrease in pain and a return to sport within two months, and just six months after the trial was completed.
A research performed by the Institute of Regenerative Tissue Therapy (ITRT), published by the prestigious American Journal of Sports Medicine, demonstrates how this therapy regenerates chronic lesions in the patellar tendon and opens up a new therapeutic option for this tissue, which was considered impossible to regenerate.
Adipose Tissue-Derived MSCs
In most patients, fat tissue can be harvested minimally invasively (under local or general anesthesia), providing a highly viable MSC population regardless of donor age. Similar to MSCs derived from other tissues, adipose tissue-derived MSCs have regenerative potential. As osteoarthritis is a very common joint disease, and knee osteoarthritis is the most common form, it is necessary to review scientific literature on osteoarthritis treatments with stem cells, like lipogems.
Lipogems Therapy
Lipogems therapy is a novel procedure that enhances the body’s natural ability to heal itself through the innovative power of science and biotechnology. The Lipogems method involves injecting mesenchymal stem cells into the joints. Adipose-derived mesenchymal stem cells have enormous regenerative potential. They also have a regenerative capacity independent of their age. Even older individuals can benefit from this procedure.
Injection of mesenchymal stem cells into the knee, particularly in the early stages of osteoarthritis, can stop the process of inflammation and degeneration, especially in the less advanced stages of the disease. In addition to preventing progressive physical deterioration of the articular cartilage, this treatment contributes significantly to a patient’s well-being and prevents the installation of knee prostheses.
Patellar Tendinopathy: Physiotherapeutic Treatment and Stem Cell Therapy
Injuries to the patellar tendon that connects the kneecap to the tibia are known as patellar tendinopathy or patellar tendinitis. The patellar tendon works with the muscles in the front of the thigh to extend the knee so you can kick, run, and jump. Athletes who perform frequent jumping in their sports, such as basketball and volleyball, are most likely to suffer from patellar tendonitis. However, people who don’t engage in jumping sports may develop patellar tendonitis. Patients with patellar tendinitis usually begin treatment with physical therapy to stretch and strengthen their knee muscles.
Strength Training and Stem Cell Therapy for Tendinopathies
Strength training with eccentric resistance is one of the most common treatments for tendinopathies. Alternatively, it has been demonstrated that bone marrow-derived mesenchymal stem cells (MSCs) can regenerate injured patellar tendons. Within six months of treatment, it has been observed that the structure of this tissue – which is always difficult to treat – is restored, reaching a regeneration of 40% in all injured persons, with a gradual improvement that eventually becomes complete.
Combination Therapies for Patellar Tendinopathy
It has been found that traditional management methods, including isometric or eccentric exercises, shock wave therapy, and even surgery, are not effective. As part of a rehabilitation program in chronic patellar tendinopathy, autologous expanded bone marrow mesenchymal stem cells (BM-MSC) or leukocyte-poor platelet-rich plasma (Lp-PRP) may be effective in reducing pain and improving activity levels. Traditional management, which includes isometric or eccentric exercises, shock wave therapy, and even surgery, has limited success. A combination of autologous expanded bone marrow mesenchymal stem cells (BM-MSCs) and leukocyte-poor platelet-rich plasma (Lp-PRP) and rehabilitation may reduce pain and improve activity levels in active participants with chronic patellar tendinopathy.
To learn more about stem cells, cellular therapies, and keep up to date with all the information about regenerative medicine and its advances, sign up for our international certification in regenerative medicine at www.issca.us.
- Published in Blog
Regenerative Medicine – An Overview On Stem Cell Therapy
THURSDAY, 10 NOVEMBER 2022 / PUBLISHED IN BLOG
Stem cell therapy is a form of regenerative medicine designed to repair damaged cells within the body by reducing inflammation and modulating the immune system. This phenomenon makes stem cell therapy a viable treatment option for a variety of medical conditions.
What is Stem Cell Therapy?
The term stem cell therapy refers to any treatment involving the use of viable human stem cells, including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and adult stem cells. Stem cells have the unique ability to differentiate into specific cell types necessary for repairing diseased tissues, making them ideal for tissue and organ transplantation.
The Hierarchy of Stem Cells
In general, stem cells fall into three categories based on their differentiation potential:
- Totipotent Cells: The most basic and capable of forming a complete embryo and extraembryonic tissues.
- Pluripotent Cells (Embryonic Stem Cells): Can differentiate into any of the three embryonic germ layers (ectoderm, mesoderm, and endoderm).
- Adult Stem Cells: Found in specialized tissues throughout the body, capable of differentiating into specific cell types related to their tissue of origin.
Adult stem cells are considered the gold standard for stem cell-based therapies due to their versatility and ability to maintain homeostasis throughout an organism’s lifespan.
Stem Cell Research for Treating Disease
Stem cell research has made significant advancements, particularly with induced pluripotent stem cells (iPSCs), which are generated from adult cells and share properties with embryonic stem cells. This innovation has enhanced disease identification and treatment possibilities, particularly in autologous transplants using patient-matched cells.
Applications of Stem Cells
Stem cells hold potential for treating diseases such as diabetes and heart disease due to their regenerative capabilities. Ongoing research aims to better understand how stem cells can be utilized in regenerative and reparative medicine to effectively treat various conditions.
Future Directions in Stem Cell Research
Stem cell studies continue to expand our knowledge of cell development and regeneration. Researchers are leveraging stem cells to test new drugs, develop model systems for studying normal development, and investigate the causes of birth defects.
To learn more about stem cells, cellular therapies, and new medical protocols using exosomes, sign up for our international certification in regenerative medicine at www.issca.us.
- Published in Blog
ISSCA IS PLEASED TO ANNOUNCE ITS UPCOMING REGENERATIVE MEDICINE CONFERENCE IN PAKISTAN
MIAMI, Florida, October 28, 2022 – The International Society for Stem Cell Application (ISSCA) is excited to announce a regenerative medicine conference in Pakistan. This event will occur on June 10th, 2023, at the University of Lahore
ISSCA is a global brand and a top leader in Regenerative Medicine worldwide. This society has partnered with other organizations in this field to host a symposium in Pakistan. Other key contributors are the Academy of Aesthetic and Regenerative Medicine (AARM), the University of Lahore (UOL), and the University College of Medicine and Dentistry (UCMD).
Goals of the Regenerative Medicine Conference 2023
The primary goal of this symposium is to encourage more physicians to adopt regenerative medicine in their practices. It also aims at improving the availability of such services to patients worldwide.
The regenerative medicine conference will benefit specialists and physicians that want to advance their studies in this field. Besides, it will provide the participants with more information about modern regenerative medicine products.
The conference will also help specialists access advanced technologies and understand their role in developing solutions in the medical field.
Regenerative medicine is growing at an undeniable rapid rate. As researchers continue to explore the field, they are discovering and developing more products. Specialists are also incorporating these discoveries into their clinics and offices worldwide. The symposium will help participants keep up with the exponential growth and changes in regenerative medicine.
What to Expect During the Symposium in Pakistan
The conference in Pakistan will consist of two sections, a theoretical and a practical one.
- Theoretical portion- World-class medical specialists will educate participants by sharing their experience and knowledge in regenerative medicine.
- Practical part- This session will include training on aesthetic and clinical applications of stem cell therapy. Participating physicians will also learn the best protocols for developing a safe and efficient medical practice.
If you want information on the upcoming regenerative medicine conference in Pakistan, visit https://www.issca.us.
What Dr. Fahad Usman Has to Say About This Event
Dr. Fahad Usman is the president of the Academy Of Aesthetic and Regenerative Medicine and the Director Center For Aesthetic Medicine University Of Lahore (UOL).
Here is what he has to say about the upcoming symposium- ‘This collaboration will identify new horizons for Regenerative Medicine in Pakistan. The event will not only benefit the doctors’ community in the country by putting Regenerative Medicine on the canvas but also increase business opportunities for investors looking for a new market for stem cell technology.
What Benito Novas Has to Say About the ISSCA
Benito Novas is the CEO of Global Stem Cells Group and Managing director of the International Society for Stem Cell Application (ISSCA). As a leader in regenerative medicine, he agrees the partnership aligns with the company’s extension plan.
Here is what he has to say- ‘The main aim of ISSCA is to spread the benefits of regenerative medicine throughout the world. We are committed to helping physicians and patients around the globe benefit from regenerative medicine
Conference Sponsors
ISSCA recognizes the significance of the 2023 Pakistan symposium in the growth of regenerative medicine. Hence, it’s grateful to the following key sponsors:
- Global Stem Cells Group
- N-Biotek
- Biotrend
- University College of Medicine and Dentistry (UCMD)
About ISSCA
The International Society for Stem Cell Application is a diverse community of physicians and scientists. The members of this nonprofit organization aspire to lessen human suffering by treating diseases. Likewise, they aim to utilize advanced science, regenerative medicine practices, and technology to offer better treatments.
ISSCA benefits its members by supporting and facilitating the advancement of regenerative medicine. The vision of this society is to be a recognized leader that promotes excellence while setting standards in various fields of regenerative medicine. Such include:
- Research
- Certification
- Publication
- Training
ISSCA recognizes the importance of certification and medical standards. That’s why it’s holding the Regenerative Medicine Conference in Pakistan. ISSCA also offers certification training in all cities worldwide.
If you want to advance your studies in regenerative medicine, plan to attend this conference.
About Global Stem Cell Group (GSCG)
The Global Stem Cell group comprises several companies dedicated to stem cell research and medicine. GSCG wants to increase patients’ access to advancements in this field. The company is also a reliable source of innovation and knowledge on the roles of stem cells in modern medicine.
GSCG liaises with educators, physicians, policymakers, and regulators to promote stem cell technology. Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
Safe Harbor Statement:
Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registrat
- Published in News
Global Stem Cells Group, Announces Launch of New Stem Cells and Regenerative Medicine Clinic in CDMX
Miami, FL, October 28, 2022 – Global Stem Cells Group announces a new partnership that enhances its goal of establishing its therapies and technology to meet market demand in populated areas of the world.
This collaboration with STEM LIFE clinic’s new facility and Dr. Vanessa Rodriguez Pares, currently one of the most prestigious aesthetic clinics in Mexico City, is expected to promote a high level of service in regenerative medicine throughout the country.
As part of this effort, the International Society for the Application of Stem Cells (ISSCA) has granted Dr. Vanessa Rodriguez Peers affiliation and use of their brand, products, therapies and training on how to apply stem cell therapies.
“This new partnership aims to expand the Global Stem Cells Group (GSCG) brand and create centers of excellence in cell therapy to meet the high demand in the Mexican market,” said Benito Novas, CEO of Global stem cells group “GSCG is rapidly expanding its global operations as it seeks to become a major player in the lucrative regenerative medicine industry. To achieve our expansion plans, our organization is partnering with healthcare providers specializing in regenerative medicine with at least five years of experience in the healthcare sector.”
Stem cell therapy is becoming an increasingly effective clinical solution for treating conditions that traditional or conventional medicine only offers within palliative care and pain management. Patients around the world are seeking a natural regenerative alternative without the potential risks and side effects sometimes associated with conventional pharmaceuticals.
The opening of this center, which will include the construction of an autologous tissue processing laboratory and an allogeneic tissue bank, will help stem cell therapy and regenerative medicine finally move from being an elective procedure to being accessible to patients throughout Mexico.
About Dr. Vanessa Rodriguez Pares
Dr. Vanessa Rodriguez Pares is a specialist in aesthetic medicine and surgery, with special attention to obesity and overweight in all ages. Management of cosmetic surgery with a comprehensive approach to the patient, taking into account their safety and their physical, psychological and emotional needs. Specialist in ULTHERAPY treatment to perform facelift without surgery. In addition to extensive experience with cellular therapies and regenerative medicine since 2016, specializing in anti-aging techniques, hair regeneration, facial aesthetics with stem cell assisted lipotransfer among other techniques.
About the Global Stem Cell Group
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products, and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators, and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website
www.stemcellsgroup.com or call +1 305 560 5331
- Published in News
Global Stem Cells Group Announces the Opening of a Multi-Specialty Regenerative Medicine Center in Cancun
Global Stem Cells Group has just announced the official opening of a new multi-specialty regenerative medicine center in Cancun. The new center is intended to incorporate different treatments based on regenerative medicine as well as to serve as a multi-specialty training center in the field of regenerative medicine and cellular therapies, offering doctors and patients the most advanced treatments in cell therapy worldwide.
The Cellular Hope Institute, as this facility was named, will also strive to pursue several objectives that will benefit patients and medical experts worldwide. It is expected to be a medical hub that will offer the best treatments for patients suffering from multiple conditions such as autoimmune deficiencies, sports injuries, chronic degenerative diseases and pediatric diseases.
Benito Novas says. “Our goal is to solve the problem and alleviate the condition, not just attempt to treat it. We are committed to offering top-notch technology available and quality care, emphasizing that our patients are always our number one priority. Our highly qualified team of experts are always ready to assist you at Cellular Hope Institute.”
The Center utilizes comprehensive stem cell treatment protocols that employ well-targeted combinations of Exosomes, allogeneic human Mesenchymal cells, autologous bone marrow and Adipose derived stem cells to treat the diseases and conditions listed above. The treatment plans are mostly focused on a systemic or whole-body approach to ensure patients receive the highest quality and quantity of cellular products available today.
Cellular Hope Institute will also be a center that will offer specialized regenerative medicine courses for physicians. Primarily, it is expected to be a resource center that will train doctors to incorporate modern regenerative medicine practices into their offices.
Our focus is to incorporate multiple specialties into separate programs within this training hub. Industry experts are expected to join the facility and offer the latest information about various compounds in the stem cell market, such as Mesenchymal stem cells, umbilical cord derived products, exosomes and many other stem cell products. We plan to target physicians who want to incorporate the treatment solutions into their practices, and the separate programs are designed to reach a wide array of practitioners.
In addition, Cellular Hope Institute also expects to have a fully functional manufacturing laboratory that seeks to elaborate the cellular products. The laboratory is already equipped with the latest and innovative technology to ensure it offers the best stem cell products and treatments. The facility will have enough capacity to store and distribute cellular products, including cells and exosomes. We expect it to be the primary supply center for doctors all over Mexico. The inauguration will mark a step closer to pursuing cell therapy, regenerative medicine, and modern tissue engineering options globally.
The opening of this center is an effort by Global stem Cells Group to continue its mission to reduce the suffering of patients and offer a new healing alternative. It is the commitment of scientists and doctors who believe in the potential of regenerative medicine as a standard treatment that should be in every doctor’s office worldwide.
To learn more about the cellular hope institute, visit its website here: https://cellularhopeinstitute.com/
- Published in News
GSCG Announces the Appointment of Dr. Rafael Moguel as New Chief Medical Officer (CMO) of Cellular Hope Institute Cancun
Global Stem Cells Group (GSCG) has announced the appointment of Dr Rafael Moguel as the new Chief Medical Officer (CMO) of Cellular Hope Institute Cancun.
Dr. Moguel, Fellow of the Society for Cardiac Angiography and Intervention (SCAI), Member of the Mexican Society for Interventional Cardiologists, and Member of the Latin American Society for Interventional Cardiology, comes with a wealth of experience and training.
As CMO with vast knowledge and experience, Dr Moguel is expected to change the direction of Cellular Hope Institute Cancun, which offers patients the best treatments in multiple areas, such as sports medicine, pediatric care, chronic degenerative disease, and autoimmunity. It’s a multi-specialty training center for cellular therapies and regenerative medicine, offering the most advanced treatments in cell therapy.
“I have full confidence in the appointment of Dr Rafael Moguel as the CMO of Cellular Hope Institute Cancun,” said Benito Novas, CEO of Global Stem Cells Group. The CEO also expressed his satisfaction in Dr Moguel’s abilities and experience, and is confident that (Dr Moguel) will advance the objectives of Cellular Hope Institute and propel it to new heights.
With his impressive resume, Dr. Moguel has served in various capacities across several top medical institutions. He was the assistant professor for Cardiology and Interventional Cardiology at Hospital 1° de Octubre, where he also handled hemodynamics and internal medicine.
In his acceptance speech, Dr Moguel said, “I want to affirm and reaffirm my commitment to the goals of Cellular Hope Institute.” With his elaborate working experience and professionalism in cellular therapy, he expressed his confidence in rising to the expectations of Cellular Hope Institute.
Dr. Moguel received his medical degree at Universidad Veracruzana in 1983. He holds a valid certification by the Mexican Cardiology Board for Interventional Cardiology. With more than 10,000 interventional procedures, most notably peripheral and brain intervention, coronary, pacemakers and vein interventions, we believe Dr. Moguel has all it takes to propel Cellular Hope Institute to the next level.
The appointment of Dr. Moguel comes barely two months after an earlier announcement by GSCG about opening the multispecialty regenerative medicine center in Cancun. The facility’s main objective is to incorporate different treatments basing on regenerative medicine, and serve as a training center for cellular therapies and regenerative medicine.
We believe Dr. Moguel’s rich background as an assistant professor and head of interventional cardiology and hemodynamics positions him as the best candidate to run Cellular Hope Institute. His experience is expected to make this facility one of the best cellular therapy centers worldwide, and provide more specialized treatment for patients requiring regenerative medicine.
About Cellular Hope Institute
This facility is a center for both patients and medical experts worldwide, and its main objective is to benefit medical experts and patients globally. The facility achieves this objective through offering the best treatments for patients with multiple conditions, such as spinal cord injury, chronic obstructive pulmonary, sports medicine, and autoimmunity, among others. If you need more information about Cellular Hope Institute, please contact us today.
About the Global Stem Cell Group
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products, and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators, and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website.
- Published in News
ISSCA Announces Upcoming Regenerative Medicine Conference In Iraq
The International Society for Stem Cell Application (ISSCA) is pleased to announce one of the most exciting conferences of the year – the Regenerative Medicine Conference. The conference will take place at the Plaza Hotel-Kirkuk Iraq, on November 11, 2022.
About the Regenerative Medicine Conference 2022
The goal of the conference is to encourage more physicians to utilize methods of practicing regenerative medicine so that it can be readily available to patients globally, especially in countries where advanced medical procedures aren’t normally accessible.
The ideal participants are physicians and specialists in Iraq who want to further their education in regenerative medicine, and learn how to incorporate various cell therapies into their practice.
Participants will gain exclusive access to the latest state-of-the-art technologies of biologics and regenerative medicine products and learn how they are applicable. Furthermore, participants will acquire knowledge on how regenerative medicine can play a major role in developing solutions for current problems in the medical field, ultimately allowing them to provide better treatment for their patients.
The Main Speakers of the Regenerative Medicine Conference 2022
The Regenerative Medicine Conference features a two-fold curriculum:
- A theoretical portion where four leading world-class medical specialists will share their knowledge and experience with participants via lectures; and
- A practical portion where participants will be trained on applying the clinical and aesthetic methods of stem cell therapy. In this portion, physicians will learn the proper protocols to safely and effectively apply these methods.
ISSCA is proud to announce the following speakers:
- M. Salih Yildirim, ISSCA’s Head of the Middle East Operations
- Mehmet Veli Karaaltin, Founder of Dr. Karaaltin Clinic, an Aesthetic, Plastic, and Reconstructive Surgery Clinic
- Melih Can Sezhic, Plastic Reconstructive, and Aesthetic Surgeon & Regenerative Medicine Specialist
- Hilmi Karadeniz, Doctor of Medicine, Specializing in Orthopedics and Traumatology
Sponsors
ISSCA would like to thank the people who are making this conference possible
- Global Stem Cells Group
- Regen Clinic
- Biotrend
- Karaaltin
- Sportoteam
Without the generosity of these people and brands, the Regenerative Medicine Conference would not be able to exist, and ISSCA is extremely thankful for the support.
About the International Society for Stem Cell Application
The International Society for Stem Cell Application (ISSCA) is a multifaceted community of physicians and scientists with a shared mission to treat diseases and lessen human suffering through advances in science, technology, and regenerative medicine. ISSCA strives to serve its members by continuing to advance in the field of regenerative medicine
ISSCA’s vision is for its members to become world leaders in setting standards and promoting excellence in regenerative medicine, related education, certification, research, and publications.
ISSCA understands that physicians need to keep their education and skills current, which is why ISSCA is holding this exciting Regenerative Medicine Conference in Iraq. Moreover, ISSCA offers certification training in cities all across the globe to encourage participants to practice regenerative medicine and make it widely accessible to patients everywhere.
Are you looking to further your education in regenerative medicine? Don’t miss out on this opportunity! To participate in this year’s Regenerative Medicine Conference, contact us on our website
About Global Stem Cells Group
Global Stem Cells Group is the parent company of six companies that are dedicated to stem cell research, solutions, and technology training. The group was founded in 2012 and combines dedicated researchers, patient educators, and physician trainers with the shared goal of meeting the need for high-end stem cell solutions and treatments.
Given that the group has a singular focus in this field, it is uniquely positioned to become the global leader in cellular medicine. In addition, by bringing together leading professionals in cellular medicine, it can discover issues that the industry faces and focus its research and development in this area. This specialization has, undoubtedly, enabled it to come up with solutions that address some of the significant issues that most stakeholders are facing in the industry.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
- Published in News
